http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109265545-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1a2a3aea0ca9b824c17551d36c2308a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 |
| filingDate | 2018-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a7b10c2bcca05d167faa8eae0950a7c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d33e703b9dedb9de37c57a4dcc106ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa6d927afea1c11ec5e36a467d633414 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e1e8bdc4d88eedb963444fa3b1e63b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2ce682d6d0e74d65f0ff978954d8b2d |
| publicationDate | 2019-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109265545-A |
| titleOfInvention | Mouse anti-human C1orf109 monoclonal antibody and preparation method and application thereof |
| abstract | The invention provides a mouse anti-human C1orf109 monoclonal antibody, a preparation method and application thereof, and belongs to the technical field of life sciences. The technical scheme is: using human embryonic kidney cells to amplify C1orf109 gene; preparing recombinant expression vector PET28a-C1orf109; transforming Escherichia coli; inducing C1orf109 protein; immunizing BALB/c mice, cell fusion; inoculating BALB/c mice, preparing ascites The mouse anti-human C1orf109 monoclonal antibody was extracted and purified. The mouse anti-human C1orf109 monoclonal antibody provided by the invention can specifically bind to the C1orf109 protein, and has high affinity and high specificity. The homologous region sequence of the cell death-inducing cell of C1orf109 protein, which can regulate human cell death, significantly improves the specificity and reliability of C1orf109 protein immunodetection compared with polyclonal antibody. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113278072-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113278072-B |
| priorityDate | 2018-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 82.